Create a free account to see ACCE Scores
Sign up for free to unlock scores, score breakdowns, and stock analysis.
WGS
↓ PDF (Pro)GeneDx Holdings Corp. Class A Common Stock
HealthcareDiagnostics & ResearchUnited StatesNASDAQ
$33.62
-2.58%today
MKT CAP
$998M
-48.5% · 1Y
Earnings History
+371.7%
+15.9%
+16.7%
-1407.8%
Q2 '25
Q3 '25
Q4 '25
Q1 '26
Analyst Targets
Current price
$33.62
Low
$55.00
Analyst Mean
$97.56
High
$170.00
9 analystsStrong Buy
Full Financials
Trailing P/E-
Forward P/E19.7x
EV/EBITDA-
Price/Sales-
Dividend Yield-
Revenue Growth YoY-
Earnings Growth YoY-
Revenue Growth QoQ-15.5%
5y Revenue CAGR+22.1%
5y Earnings CAGR-
Gross Margin-
Operating Margin-
Net Margin-
ROE-
Debt / Equity-
Free Cash Flow-
Insider Ownership12.3%
Institutional Ownership109.6%
Short % of Float26.61%
Days to Cover5.6d
1 Week-49.4%
1 Month-
3 Months-
6 Months-
YTD-
1 Year-
3 Years-
5 Years-
vs 50-day SMA-
vs 200-day SMA-
vs 52w High-
vs 52w Low-
Insider Transactions
| Filer | Role | Type | Shares | Price | Value | Date |
|---|---|---|---|---|---|---|
| STUELAND KATHERINE | Chief Executive Officer | Sale | 2,172 | $64.12 | $0.14M | 2026-04-29 |
| STUELAND KATHERINE | Chief Executive Officer | Other | 3,874 | - | - | 2026-04-29 |
| FEELEY KEVIN | Chief Financial Officer | Sale | 392 | $65.19 | $0.03M | 2026-04-29 |
| FEELEY KEVIN | Chief Financial Officer | Other | 754 | - | - | 2026-04-29 |
| STUELAND KATHERINE | Chief Executive Officer | Sale | 46,933 | $61.29 | $2.96M | 2026-03-26 |
Top Holders
| Holder | Type | % Held | Value | Δ Shares | As of |
|---|---|---|---|---|---|
| Corvex Management LP | institution | 10.30% | $0.11B | +0.00% | 2025-12-31 |
| Casdin Capital, LLC | institution | 10.13% | $0.10B | +0.00% | 2025-12-31 |
| Blackrock Inc. | institution | 5.25% | $0.05B | +2.03% | 2025-12-31 |
| Goldman Sachs Group Inc | institution | 4.11% | $0.04B | +4.48% | 2025-12-31 |
| Vanguard Group Inc | institution | 4.01% | $0.04B | +1.59% | 2025-12-31 |
| Franklin Resources, Inc. | institution | 3.68% | $0.04B | +60.41% | 2025-12-31 |
| Westfield Capital Management Co LP | institution | 3.43% | $0.04B | +87.15% | 2025-12-31 |
| Summit Partners Public Asset Management LLC | institution | 3.10% | $0.03B | +11.78% | 2025-12-31 |
| Oracle Investment Management Inc | institution | 2.98% | $0.03B | -0.60% | 2025-12-31 |
| FMR, LLC | institution | 2.80% | $0.03B | +65.45% | 2025-12-31 |
| ARK ETF Trust-ARK Innovation ETF | fund | 2.39% | $0.02B | +28.97% | 2026-02-28 |
| VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund | fund | 1.98% | $0.02B | -0.56% | 2025-12-31 |
| Franklin Custodian Funds-FRANKLIN DYNATECH FUND | fund | 1.68% | $0.02B | +100.00% | 2025-12-31 |
| iShares Trust-iShares Russell 2000 ETF | fund | 1.56% | $0.02B | -0.65% | 2026-03-31 |
| SmallCap World Fund Inc | fund | 1.32% | $0.01B | +292.04% | 2025-12-31 |
| AIM Counselor Series TRT -Invesco Discovery Fd. | fund | 1.28% | $0.01B | +5.13% | 2026-02-28 |
| HARBOR FUNDS-Harbor Small Cap Growth Fund | fund | 0.99% | $0.01B | +11.52% | 2026-01-31 |
| LORD ABBETT DEVELOPING GROWTH Fd., INC.-Lord Abbett Developing Growth | fund | 0.95% | $0.01B | -0.34% | 2026-01-31 |
| ARK ETF Trust-ARK Genomic Revolution ETF | fund | 0.88% | $0.01B | +26.32% | 2026-02-28 |
| Fidelity Securities Fund-Fidelity Small Cap Growth Fund | fund | 0.81% | $0.01B | +0.00% | 2026-02-28 |
Unlock Full Financials
Growth metrics, valuation multiples, and profitability ratios on Starter+.
Recent Alerts
No alerts yet for WGS.
Want deep analysis?
This stock isn't in the ACCE researched universe. Browse 300+ stocks with full thesis, scores, and financial models.
Browse ACCE Indices →Get the ACCE weekly digest
Index returns, picks recap, score movers - every Sunday. No fluff.